- Nucleic Acid Test
(NAT) (Technology) Global Competitor Market Share Positioning for 2019 & 2025
Haoyuan now is the only local maker of approved nucleic acid test
agents in China, Medigen said, in addition to international pharmaceutical maker Roche.
The agreement between the companies expands on an earlier collaboration to create a new form of nucleic acid tests
. Under the newest agreement, Millipore's global sales organization will sell the MTC-NI assay until the newest sample preparation products and higher sensitivity assays under development by the two companies are launched.
Prevention of West Nile virus transmission by blood transfusion: a comparison of nucleic acid test
This technology can produce a highly multiplexed, 20-minute, nucleic acid test
result using room temperature-stable consumables.
The investigational APTIMA HPV assay is an amplified nucleic acid test
that detects 14 high-risk HPV types that are associated with cervical cancer.
Food and Drug Administration (FDA) has granted 510(k) clearance permitting Northbrook, IL-based Nanosphere to market its CYP2C19 Nucleic Acid Test
on the automated sample-to-result Verigene[R] System.
To meet this working definition, cases had to satisfy one or more of the following three criteria: 1) HIV-1/HIV-2 type-differentiating antibody immunoassay (e.g., Bio-Rad Multispot HIV1/HIV-2 Rapid Test) positive for HIV-2 but negative for HIV-1, 2) positive HIV-2 nucleic acid test
(DNA or RNA), 3) positive HIV-2 immunoblot and negative or indeterminate HIV-1 immunoblot.
The nucleic acid test
(NAT) category includes a variety of diagnostic tests that analyze nucleic acids, either DNA or RNA, extracted from clinical samples such as blood, tissue or tumor samples.
All prospective living organ donors should have their initial serologic tests for HIV supplemented with repeat testing with a combination of an HIV serologic test and a nucleic acid test
as close to the time of organ donation as possible, but no longer than 7 days before organ donation.
M2 PHARMA-October 13, 2014-Nanosphere gains FDA nod for additional viral targets on Verigene Enteric Pathogens nucleic acid test